Angiodynamics (ANGO) Change in Inventory (2010 - 2026)

Angiodynamics' Change in Inventory history runs 17 years deep, the most recent figure standing at -$6.5 million for Q2 2026.

• Quarterly Change in Inventory fell 463.96% year-over-year to -$6.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$10.0 million (down 845.88% YoY) and the FY2026 annual result came in at -$10.0 million, down 845.88% from the prior year.
• Change in Inventory was -$6.5 million for Q2 2026 at Angiodynamics, up from -$7.1 million in the prior quarter.
• Across five years, Change in Inventory topped out at $6.2 million in Q3 2022 and bottomed at -$7.1 million in Q1 2026.
• A 5-year average of $676777.8 and a median of $836500.0 in 2023 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2022 — Change in Inventory jumped 905.71% — and 2024, when it slumped 577.3%.
• Angiodynamics' Change in Inventory stood at $5.6 million in 2022, then slipped by 23.65% to $4.3 million in 2023, then tumbled by 70.73% to $1.2 million in 2024, then soared by 162.48% to $3.3 million in 2025, then slumped by 296.98% to -$6.5 million in 2026.
• Business Quant data shows ANGO's Change in Inventory at -$6.5 million in Q2 2026, -$7.1 million in Q1 2026, and $3.3 million in Q4 2025.